Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease
- PMID: 22260521
- DOI: 10.1111/j.1478-3231.2011.02749.x
Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease
Abstract
Background/aims: Serum alanine aminotransferase (ALT) is an easily available, low-cost screening tool for detecting silent chronic liver disease. Recent studies have suggested that the currently accepted healthy ALT thresholds be lowered.
Methods: In this retrospective cross-sectional study, we determined upper thresholds for ALT values in a nationally representative healthy cohort (n = 3337) from the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Sensitivity and specificity of the currently used ALT threshold (40 IU/L, regardless of gender) was compared against study-derived, gender-specific ALT thresholds for detecting individuals at risk for chronic liver disease in 27 913 health check-up participants.
Results: The 95th percentile levels for ALT in healthy weight, metabolically normal, liver disease-free KNHANES participants were 34 IU/L for men and 25 IU/L for women. The prevalence of ALT elevation among health check-up participants was 11.0% in currently used thresholds, and increased to 22.6% with study-derived, gender-specific thresholds. Of the population who were additionally defined to have elevated ALT levels under new ALT threshold, 65.7% were at risk for chronic liver disease. Sensitivity for detecting individuals at risk for chronic liver disease improved from 18 to 33% with new thresholds whereas a trade-off in specificity (from 96 to 88%) was observed.
Conclusions: It is recommendable to lower the current ALT thresholds to better identify individuals at risk for chronic liver disease.
© 2012 John Wiley & Sons A/S.
Similar articles
-
Upper reference limits for aminotransferase activities and the prevalence of elevated aminotransferase activities in a Korean population.J Clin Gastroenterol. 2013 Jan;47(1):76-82. doi: 10.1097/MCG.0b013e31825752a4. J Clin Gastroenterol. 2013. PMID: 22739218
-
SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.Gastroenterology. 2010 Apr;138(4):1357-64, 1364.e1-2. doi: 10.1053/j.gastro.2009.12.052. Epub 2010 Jan 11. Gastroenterology. 2010. PMID: 20064512 Free PMC article.
-
Healthy range for serum ALT and the clinical significance of "unhealthy" normal ALT levels in the Korean population.J Gastroenterol Hepatol. 2011 Feb;26(2):292-9. doi: 10.1111/j.1440-1746.2010.06481.x. J Gastroenterol Hepatol. 2011. PMID: 21261719
-
Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases.Ann Hepatol. 2025 Jan-Jun;30(1):101900. doi: 10.1016/j.aohep.2025.101900. Epub 2025 Mar 13. Ann Hepatol. 2025. PMID: 40089150 Review.
-
[ALT screening for chronic liver diseases: scrutinizing the evidence].Z Gastroenterol. 2010 Jan;48(1):46-55. doi: 10.1055/s-0028-1109980. Epub 2010 Jan 13. Z Gastroenterol. 2010. PMID: 20072996 Review. German.
Cited by
-
Upper Normal Limits of Serum Alanine Aminotransferase in Healthy Population: A Systematic Review.Middle East J Dig Dis. 2020 Jul;12(3):194-205. doi: 10.34172/mejdd.2020.182. Middle East J Dig Dis. 2020. PMID: 33062225 Free PMC article. Review.
-
Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels.World J Gastroenterol. 2013;19(14):2256-61. doi: 10.3748/wjg.v19.i14.2256. World J Gastroenterol. 2013. PMID: 23599653 Free PMC article.
-
Factors Associated with Antiretroviral Therapy Toxicity Out-Comes in Patients with and without Hypertension.Int J Environ Res Public Health. 2022 Sep 3;19(17):11051. doi: 10.3390/ijerph191711051. Int J Environ Res Public Health. 2022. PMID: 36078765 Free PMC article.
-
KASL clinical practice guidelines for management of chronic hepatitis B.Clin Mol Hepatol. 2022 Apr;28(2):276-331. doi: 10.3350/cmh.2022.0084. Epub 2022 Apr 1. Clin Mol Hepatol. 2022. PMID: 35430783 Free PMC article. No abstract available.
-
Factors associated with prognostic or treatment outcomes in HIV/AIDS patients with and without hypertension in Eswatini.Sci Rep. 2021 Jun 21;11(1):12955. doi: 10.1038/s41598-021-92185-0. Sci Rep. 2021. PMID: 34155234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical